What's breaking now, across thousands of outlets.
Quid-pro-quo vaping policies, ebola vaccine efforts, and more health news from Morning Rounds
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
[New Times] The closure of 109 alcoholic beverage factories in Rwanda within a matter of days was a necessary intervention to protect public health.
The convenience of taking a daily pill to lose weight is attracting a new group of patients to try emerging oral GLP-1 drugs such as Foundayo and Wegovy.
A provincial government in Nepal has legalized the use and growing of marijuana for medical purposes despite a national ban.
Expedition Therapeutics, which has raised nearly $300 million to date, is studying a drug it believes to have notable advantages over other COPD treatments either in development or on the market.
A US biotech with a slightly different approach to the burgeoning NewCo model has raised another $115 million for its China-sourced COPD drug candidate.
